Good Lifestyle

Monday, drug societyPfizer announcedthat the latest data from their coronavirus vaccine are extremely promising. According to them, the vaccine was over 90% effective in CVIV-19 prevention that means that it has a lot exceeded the expectations of health experts around the world.

"With today's news, we are closer to provide people around the world with advantageous advance to help put an end to this global health crisis," said Albert Bourla CEO of Pfizer Bourla in a statement. "We look forward to sharing additional efficiency and security data generated by thousands of participants in the coming weeks." In response, stocks climbed and hope to get up. Read to see what this news really means and to ensure your health and health of others, do not miss theseWithout signs that you have already had coronavirus.

What does this new vaccine mean?

"It seems that 90% fewer symptomatic cases of COVID-19 occur in the arm of the study that received two vaccinations of three weeks remotely, which was compared to a placebo group", "Darren Mareiniss, MD, Facece, Emergency medicine doctor at Einstein Medical Center in Philadelphia and expert in preparation for the pandemic explains toEat this, not that! Health.

As part of the tests, 43,000 people received two doses of vaccine or placebo. On total COVID-19 infections, barely 10% in the group of those who received the vaccine while 90% had been achieved because of the placebo. According to Pfizer, the vaccine begins to work its magic and offers protection against virus potentially mortal seven days after the second dose and 28 days after the first.

So far, they monitored 94 confirmed cases, with a goal of reaching 164 to complete the trial. They hope to receive an emergency use of the FDA after volunteer monitoring for two months after their second dose, which should be the third week of November.

RELATED:Malic habits on the planet, according to doctors

The results are "very encouraging" but it's not a curative treatment yet

While Dr. Mareiniss finds the results "very encouraging", he emphasizes that they are in no way an instant and miraculous healing for the virus, responsible for the death of more than 238,000 Americans in just nine months.

Several factors must be taken into account. First, the data is not yet peer-examined, an important component of the verification of a scientific study or trial. "It's hard to see the complete picture and relive in a critical way simply a press release," he explains.

It also emphasizes that while the Pfizer vaccine can help prevent Covid-19 infection, "it is difficult to know how much long-term immunity can last" this information.

There is also the issue of supply, distribution and other logistics. "We need to consider that there will be limited vaccine supplies and the United States / hospitals are already working on allocation guidelines," he explains. If the vaccine is safe and effective, Pfizer believes that it could produce 50 million doses by the end of the year. "The task of distributing the vaccine will also be difficult." And, one of the logistical problems is the mRNA vaccine must be stored at an extremely cold temperature - negative 70 degrees Celsius. "This facilitates the transportation and distribution of stimulating vaccine," he says.

As for yourself, until you hear otherwise: wearing afacial maskAnd to cross this pandemic with your healthiest, do not miss these35 places you are most likely to catch Covid.